Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatobiliary bile acid transport system is a coordinated network of membrane proteins and regulatory factors responsible for the uptake, intracellular transport, and canalicular secretion of bile acids and other cholephilic compounds [1.1.1, 1.2.1]. Key components include basolateral uptake transporters like the Sodium/taurocholate cotransporting polypeptide (NTCP) and canalicular efflux pumps such as the Bile salt export pump (BSEP) and Multidrug resistance-associated protein 2 (MRP2) [1.1.3, 1.3.4]. This machinery is essential for maintaining bile flow, facilitating the absorption of dietary lipids, and eliminating metabolic waste and xenobiotics from the body [1.1.1, 1.2.3]. Dysregulation or genetic mutations in these transporters lead to cholestasis, a condition characterized by the accumulation of toxic bile acids within hepatocytes, resulting in liver injury, fibrosis, and cirrhosis [1.1.2, 1.2.2]. Therapeutic strategies often target this system through nuclear receptors like the Farnesoid X receptor (FXR) to modulate transporter expression or by inhibiting intestinal reabsorption to reduce the total bile acid pool [1.3.1, 1.3.5]. Monitoring efficacy and safety typically involves measuring serum bile acids and liver enzymes such as alkaline phosphatase [1.3.1].
Agonism of the Farnesoid X receptor (FXR) to downregulate bile acid uptake and synthesis while upregulating efflux; inhibition of the apical sodium-dependent bile acid transporter (ASBT) to reduce enterohepatic circulation; induction of alternative basolateral efflux pathways; and direct inhibition of the bile salt export pump (BSEP) as a toxicological mechanism.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatobiliary bile acid transport system.